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Abstract  
The gut microbiota (GM) stimulates the immune system to facilitate appropriate immune responses at local and distal 
sites of virus infection. However, the impact of distal virus infections in modulating the composition of GM is less clear. 
Here, a mouse model was used to examine the effect of influenza a virus (IAV) infection on the composition of GM in mice 
that did or did not receive oral treatment with broad spectrum antibiotics (ABX). We focused on ABX treatment of 3 
weeks old juvenile mice, as this represents a dynamic time in the establishment of GM and immunity, followed by mock- 
or IAV-infection 2 weeks later. Mice were subsequently assessed for changes in body weight, viral load in the respiratory 
tract and the composition of GM. As anticipated, oral ABX treatment reduced the diversity of GM and ABX-treated mice 
showed exacerbated disease, characterized by enhanced weight loss and increased virus titers in the upper and lower 
airways. Surprisingly, IAV infection also increased the diversity of GM in ABX-treated mice, resulting in a microbial 
composition qualitatively and quantitatively different to mock-infected ABX-treated mice and IAV-infected mice that did 
not receive ABX treatment. Specifically, IAV infection increased the relative abundance of eight different bacteria in GM in 
ABX mice compared to the GM in mock-infected ABX mice. These findings confirm an important role for GM in functional 
immune defense against IAV infection in juvenile mice, consistent with previous studies in adult animals. Moreover, we 
report for the first time that distal IAV infection of the airways can enhance the diversity of an ABX-compromised GM. 
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Abbreviations: ABX: broad-spectrum antibiotic; CON: 
control; i.n: intranasal; GM: Gut microbiota; i.t: 
intratracheal; IAV: influenza A virus; MDCK: Madin-Darby 
canine kidney; NMDS: Non-metric multidimensional 
scaling; OUT: Operational Taxonomic Units; p.i: post-
infection; PFU: plaque forming units; QIIME: Quantitative 
Insight In to Microbial Ecology.  
 
Introduction 
Gut microbiota (GM) dysbiosis plays an important role 
in the etiology of an array of diseases, including resistance 
towards infections caused by Antharam, et al. [1], 
Koenigsknecht, et al. [2], Schubert [3], Zainah, et al. [4], 
parasites e.g. Toxoplasma gondii [5] and viruses e.g. 
influenza A virus (IAV) [6-9], and human 
immunodeficiency virus (HIV)-1 [10]. A homeostatic GM 
can contribute to protection against invading pathogens 
via depletion of nutrients, antimicrobial peptide 
production and/or priming of immune cells to combat 
infections at local or distal sites in the body [11,12]. 
Exposure to oral antibiotics (ABX) can alter GM diversity 
and this can differ depending on the particular ABX 
treatment [6]. In mouse models, reduced GM diversity 
during bacterial or viral challenge is known to exacerbate 
diseases e verify [2,3,6-8,13-15]. Modulation of GM 
following pre-treatment of adult mice with ABX resulted 
in exacerbated disease following subsequent IAV 
challenge, characterized by delayed virus clearance, 
reduced titers of virus-specific antibodies and impaired 
inflamma some-dependent responses by innate and 
adaptive immune cells [6,7]. Thus, commensal microbes 
appear to play a critical role in calibrating appropriate 
immune responses to IAV and other pathogens. 
 
Colonization of the gastrointestinal tract by 
microorganisms commences at birth, immediately after 
delivery, and the succession of new bacterial colonizers 
have been shown to be essential for development of the 
immune system [16-18]. Not surprisingly, reduced 
microbiota diversity as a result of ABX treatment or germ-
free conditions in early life can affect development of the 
immune system [19-21]. Making the host more vulnerable 
to infection. In mice, establishment of intestinal 
microbiota occurs after weaning between 3-5 weeks post-
partum [22]. While the impact of ABX treatment on IAV 
infection has been established in adult mice, we have 
investigated the impact of ABX treatment of juvenile 
animals (3 weeks old) given that this time is critical for 
the final establishment of GM composition.  
 
Following intranasal (i.n.) or intra tracheal (i.t.) 
inoculation of mice with seasonal IAV, epithelial cells 
lining the upper and lower respiratory tract represent the 
primary targets for IAV infection and amplification. The 
expression of particular trypsin-like proteases in the 
airways is a major factor limiting the systemic spread of 
seasonal IAV to other sites in the body. Consistent with 
this, infectious virus is generally not recovered from the 
intestinal tractor other distal organs [23,24]. 
Nevertheless, experimental infection of mice by the 
mouse-adapted IAV strain A/Puerto Rico/8/1934 (PR8, 
(H1N1)) altered GM composition and was associated with 
increase dintestinal injury [9,24]. Furthermore, one of 
these studies found that use of broad-spectrum ABX prior 
to and during PR8 infection diminished infection-related 
intestinal injury. Together, these studies are consistent 
with an indirect effect of IAV infection on the composition 
of GM and/or intestinal health in adult mice [9].  
 
Strains of human seasonal IAV show marked 
differences in their ability to infect and induce disease in 
mice. Historically, serial passage of human IAV in mice has 
been used to increase their virulence, allowing for studies 
investigating pathogen city and immune responses 
elicited to IAV infection. PR8 is a mouse-adapted H1N1 
virus that has been widely used to study IAV infection in 
laboratory mice as it readily infects the lung to induce a 
viral pneumonia, similar to that seen during severe 
disease in humans [25]. However, primary viral 
pneumonia represents the most severe pulmonary 
manifestation and is relatively uncommon in healthy 
adults during most seasonal epidemics [26,27]. Moreover, 
the virulence of the PR8 strain in mice can limit its 
usefulness, particularly in immune compromised animals 
or in juvenile mice which also show increased 
susceptibility to IAV [28]. Herein, we have investigated 
the ability of HKx31 (H3N2), an IAV strain of moderate 
virulence in mice compared to PR8 [29,30]. To infect and 
modulate the composition of GM in juvenile mice. In 
addition, we have examined the effect of oral ABX 
treatment prior to and during HKx31 infection on the 
composition of GM in juvenile mice.  
 
Materials and Methods 
Ethics Statement 
All experiments with mice were conducted with 
approval from the University of Melbourne Biochemistry 
& Molecular Biology, Dental Science, Medicine, 
Microbiology & Immunology, and Surgery Animal Ethics 
Committee. Experiments using mice were conducted with 
approval from the University of Melbourne Biochemistry 
& Molecular Biology, Dental Science, Medicine, 
Microbiology & Immunology, and Surgery Animal Ethics 
Committee (project 1413227.3), in accordance with the 
National Health and Medical Research Council (NHMRC) 
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Australian code of practice for the care and use of animals 
for scientific purposes. 
 
Experiments using 10-day embryonated chicken eggs 
were conducted with approval from the University of 
Melbourne Biochemistry & Molecular Biology, Dental 
Science, Medicine, Microbiology & Immunology, and 
Surgery Animal Ethics Committee (project 1714213), in 
accordance with the National Health and Medical 
Research Council (NHMRC) Australian code of practice for 
the care and use of animals for scientific purposes. Eggs 
were obtained from Hy-Line Australia (Bags hot, Victoria, 
Australia). 
 
Mice and Virus 
C57BL/6 male mice were bred and housed in specific 
pathogen-free facilities at the Department of Microbiology 
and Immunology, University of Melbourne, Australia. IAV 
strain HKx31 is a high-yielding reassortant of A/PR/8/34 
(PR8, H1N1) and A/Aichi/2/1968 (H3N2), and expresses 
the H3N2 surface glycoproteins. HKx31 was grown in 10-
day embryonated hen’s eggs by standard procedures [31]. 
Viral stock was stored at -80°C. Titers of infectious virus 
were determined by standard plaque assay on Madin-
Darby canine kidney (MDCK, American Type Culture 
Collection (ATCC)) cells [31]. Expressed as plaque-
forming units (PFU)/ml. 
 
Antibiotic Treatment and IAV Infection of Mice 
Following weaning at 3 weeks of age, mice received 
either (i) normal drinking water, or (ii) drinking water 
supplemented with ampicillin (0.5 mg/ml), gentamicin 
sulphate (0.5 mg/ml), and metronidazole (0.5 mg/ml) (all 
from Sigma Aldrich, collectively called ABX). Mice were 
treated for 3 weeks and ABX water was changed every 
third day. After 2 weeks ±ABX treatment (i.e. 5 weeks of 
age), mice were anaesthetized using isoflurane and 
infected via the intranasal (i.n.) route with 100 PFU of 
HKx31 in 50µl PBS. Control mice were mock-infected with 
50µl of PBS alone. Mice were weighed daily and assessed 
for signs of clinical disease. Animals that had lost >15% of 
their original body weight and/or displayed evidence of 
pneumonia were culled. On day 7 p.i., mice were culled 
and nasal and lung tissues collected from IAV-infected 
mice were homogenized in 1ml of PBS, clarified by 
centrifugation and stored at -80°C. Titers of infectious 
virus were determined by plaque assay MDCK cells [31]. 
All experiments with mice were conducted with approval 
from the University of Melbourne Biochemistry & 
Molecular Biology, Dental Science, Medicine, Microbiology 
& Immunology, and Surgery Animal Ethics Committee. 
 
Fecal Sample Collection and Microbial DNA 
Extraction 
Fecal samples were collected from mice on the day of 
infection (day 0 p.i., mice = 5 weeks of age) and 
immediately prior to euthanasia (day 7 p.i., mice = 6 
weeks of age) and stored at -80°C until DNA extraction. 
Fecal samples were homogenized and DNA was extracted 
via MoBio Power Soil Kit (Mo Bio Laboratories, QIAGEN) 
and stored at -80°C prior to analysis. 
 
High Throughput Sequencing of the Gut 
Microbiota  
Fecal microbiota composition of 38 mice was 
determined using tag-encoded 16S rRNA gene MiSeq-
based (Illumina, CA, USA) high throughput sequencing. 
Cellular DNA extraction, DNA storage and sequencing 
library preparation steps were conducted as previously 
described [32]. The following adjustments: the V3 region 
of the 16S rRNA gene amplified using primers compatible 
with Nextera Index Kit (Illumina; NXt_338_F: 5′–
TCGTCGGCAGCGTC AGATGTGTATAAGAGACAG 
ACWCCTACGGGWGGCAGCAG–3′ and NXt_518_R: 5′–
GTCTCGTGGGCTCGG AGATGTGTATAAGAGACAG 
ATTACCGCGGCTGCTGG–3′). Two samples were excluded 
from the analysis due to a low read number (<10.000 
reads).  
 
The raw data set containing pair-ended reads with 
corresponding quality scores were merged and trimmed 
using fastq_mergepairs and fastq_filter scripts 
implemented in the UPARSE pipeline [33]. The minimum 
overlap length of trimmed reads (150 bp) was set to 100 
bp. The minimum length of merged reads was 150 bp. The 
maximum expected error E = 2.0, and first truncating 
position with quality score N ≤ 4. Purging the data set 
from chimeric reads and constructing de novo operational 
taxonomic units (OTU) were conducted using the UPARSE 
pipeline [33]. Quantitative Insight into Microbial Ecology 
(QIIME) open source software package [34] (1.7.0 and 
1.8.0) was used for subsequent analysis steps. The green 
genes (13.8) 16S rRNA gene collection was used as a 
reference database [35].  
 
Unweighted, generalized, and weighted UniFrac 
distance metrics were calculated from subsampled OTU 
tables (10.000 reads/sample) and visualized with non-
metric multidimensional scaling (NMDS) plots. The 
differences in ordination between categories were tested 
using Per mutational Multivariate Analysis of Variance 
using Distance Matrices, ‘Adonis’ function from R package 
‘vegan’ [36].  
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Alpha diversity measures expressed with an observed 
species (sequence similarity 97% OTUs) value were 
computed for rarefied OTU tables (10.000 reads/sample) 
using the alpha rarefaction workflow. Differences in alpha 
diversity were determined using a t-test-based approach 
employing the non-parametric (Monte Carlo) method 
(999 permutations) implemented in the compare alpha 
diversity workflow. The differences in taxa abundance 
between categories were estimated with a statistic 
framework: analysis of composition of microbes (ANCOM) 
based on non-normalized species level OTU-table [37].  
 
Results 
Oral ABX Treatment Enhances IAV-Associated 
Disease in Juvenile Mice 
Following weaning at 3 weeks of age, mice received 
normal drinking water (control (CON)) or drinking water 
supplemented with broad-spectrum antibiotics (ABX, 
gentamicin, ampicillin, and metronidazole) for 2 weeks.  
 
 
Figure 1: Oral broad-spectrum ABX treatment prior to and during IAV infection enhances IAV-induced disease in 
juvenile mice. (A) Experimental model. Following weaning of male mice at 3 weeks of age, half were immediately 
given drinking water supplemented with broad-spectrum antibiotics (ABX: ampicillin, gentamycin and metronidazole, 
0.5mg/ml) for 2 weeks and half of the mice received normal drinking water alone (control (CON)). At 5 weeks of age, 
half of the ABX and CON mice were intranasally infected with 100 PFU HKx31 (ABX-IAV and CON-IAV mice, 
respectively) and half were mock-infected with virus diluent (ABX-mock and CON-mock mice, respectively). ABX were 
maintained in the drinking water of ABX-mock and ABX-IAV mice throughout the course of infection (7 days). All mice 
were euthanized for analysis at day 7 post-infection (p.i.). Fecal samples were collected for analysis of microbiota at 
day 0 and day 7 p.i. (B) Body weight changes measured as (i) grams, (ii) percentage of original body weight on day 0 
relative to infection (CON-mock, blue, n = 10; CON-IAV, black, n = 10; ABX-mock, red, n = 10; ABX-IAV, green, n = 8), 
and (iii) percentage weight change relative to appropriate mock-infected controls (based on body weight in grams; 
CON-IAV, open black; ABX-IAV, open green). Data show the mean ± SEM for groups of 10 mice, pooled from two 
independent experiments and were analyzed by two-way ANOVA followed by Bonferroni’s post-test. a = CON-mock 
vs. ABX-mock, b = CON-mock vs. CON-IAV, c = ABX-mock vs. ABX-IAV, d = CON-IAV vs. ABX-IAV where p<0.001, 
p<0.01 and p<0.05 are denoted by 3, 2 or 1 letters, respectively.(C) Virus titers were determined in clarified 
homogenates prepared from lung and nasal tissues of IAV-infected mice. Titers from individual animals are shown 
and horizontal bars represent the mean ± SD for each group. The dashed line shows the detection limit of the assay. 
Data are pooled from two independent experiments. Data were analyzed using Student’s t-test. *p<0.05.  
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After this time, mice were infected via the intranasal (i.n.) 
route with 100plaque-forming units (PFU) of IAV strain 
HKx31 (IAV) or mock infected with an equivalent volume 
of virus diluent (mock). IAV- and mock-infected mice 
were monitored for a further 7 days with ABX present or 
absent from the drinking water (for experimental design 
(Figure 1A). Mice were weighed daily after 
commencement of ABX treatment and following IAV 
infection. Note that no clinical signs of disease were 
evident throughout the monitoring period (data not 
shown). Compared to CON mice, two weeks of ABX 
treatment resulted in a significant weight reduction on 
the day of infection (Figure 1B(i)), day -14 to 0 post-
infection (p.i.). These findings are consistent with 
previous studies showing that ABX treatment of juvenile 
mice is associated with delayed weight gain [38]. Next, we 
assessed the impact of IAV infection on weight loss in 
ABX- and CON-treated mice by examining body weight in 
grams (Figure 1B(i)) or as the percentage change in each 
of the IAV-infected groups relative to their appropriate 
mock-infected control (Figure 1B (ii)). The mock-infected 
mice, CON-mock animals showed minimal weight gains 
between day 0-7 p.i. whereas ABX-mock mice continued 
to gain weight during this time (Figure 1B (i)). These 
findings are consistent with studies showing that ABX 
treatment of adult mice is associated with increased 
weight gain [39,40]. Interestingly, when examining the 
percentage weight change compared to the appropriate 
mock-infected control, it was evident that maximum 
relative weight loss for CON-IAV animals occurred at days 
4-5 p.i., whereas ABX-IAV continued to lose weight and 
maximum relative weight loss was recorded at days6-7 
p.i. (Figure 1C (ii)). While IAV infection of both CON and 
ABX mice induced significant weight loss compared to 
respective mock-infected animals, viral replication was 
enhanced in both the upper (nose) and lower (lungs) 
respiratory tract of ABX-IAV mice compared to CON-IAV 
mice (Figure 1D). Thus, while HKx31 infection of juvenile 
CON mice was associated with weight loss and viral 
replication in the airways, ABX treatment prior to and 
during infection resulted in prolonged weight loss 
(indicative of disease) and enhanced virus replication. 
 
Parabacteroides Distasonis was the Dominating 
Taxa after Oral Antibiotic Treatment at the 
Time of IAV Infection 
To determine the effects of ABX treatment on GM 
composition at the time of IAV infection, we examined the 
microbial composition in fecal samples collected on the 
day of infection (i.e. day 0 p.i., after two weeks of ABX 
treatment) and displayed all tax a with an abundance 
threshold of 0.1%. Compared to CON mice, ABX mice 
showed an overall reduction in the relative abundance of 
most types of bacteria and the GM of ABX mice was 
dominated by Parabacteroides distasonis (Bacteroidetes) 
at levels of 87.5% in ABX mice compared to 7.4% in CON 
mice (Figure 2).  
 
 
Figure 2: Oral broad-spectrum ABX treatment changes gut microbiota diversity in juvenile mice just prior to IAV 
infection.  
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Heat map depicting taxa relative abundance reported 
as significantly different (ANCOM, p<0.05) between CON 
(n = 10) and ABX (n = 10) mice on day 0 p.i., just prior to 
IAV infection. Analyses were performed using non-
normalized, summarized to the species level OTU-table 
with abundance threshold 0.1%. Instead, members of 
S24-7 represented the dominant phyla detected in the GM 
of CON mice at 58.1% compared to just 2% in ABX mice. 
The decrease in relative abundance of most bacteria was 
paralleled by a strong reduction in the measurement of 
observed species, showing a marked reduction in the 
diversity of GM in ABX mice compared to CON mice.  
 
IAV Infection Modulates the Composition of Gut 
Microbiota in ABX Mice 
The non-metric multidimensional scaling (NMDS) 
plots based on unweighted, generalized and weighted 
UniFrac distance matrices showed significant (Adonis 
p<0.01) separation between the 4 groups, indicating clear 
qualitative and quantitative differences in microbial 
composition (Figure 3). 
 
 
 
Figure 3: IAV infection enhances the diversity of the compromised gut microbiota in ABX mice. Nonmetric 
multidirectional scaling (NMDS) plots based on unweighted (u), generalized (g), and weighted (w) UniFrac distance 
matrices. Clear separation between all 4 treatment groups on unweighted (adonis R2 =0.593; p<0.01**) and 
generalized (adonis R2 =0.675; p<0.01**). NMDS plots indicate that main differences are to be expected within low 
and semi-abundant taxa. The NMDS plot based on the weighted UniFrac distance matrix indicates differences in high 
abundant taxonomic group within ABX-IAV group (adonis R2 =0.687; p<0.01**) (w). S values represent the stress of 
each NMDS ordination. (CON-mock (blue) n=4, CON-IAV (black) n=5, ABX-mock (red) n=4, ABX-IAV (green) n=3). 
 
 
The bacterial diversity (observed species index) 
tended to increase in both of the infected groups (CON-
IAV and ABX-IAV), however this was only significant 
between ABX-mock and ABX-IAV mice (Figure 4A). 
Infection of CON mice (CON-IAV) significantly reduced the 
relative abundance of Allobaculum (Firmicutes) (Figure 
4B). Interestingly, infection of ABX mice resulted in a 
significant increase in relative abundance of severaltaxa, 
including Akkermansia muciniphila (Verrucomicrobia), 
Enterobacteriaceae and Sutterella (Proteobacteria), 
Bacteroides, Candidate phyla S24-7, Bacteroides uniformis, 
Bacteroides acidifaciens and Bacteroidales (all 
Bacteroidetes), (Figure 4C).  
 
While the number of animals, and hence fecal samples 
analyzed in the present study was relatively low, it was 
sufficient to provide statically confidence in differences in 
the diversity of GM. No doubt that the quality and 
statistical power of this data would be improved by 
additional sampling. 
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Figure 4: IAV infection increases the relative abundance of five different bacteria species in ABX mice. (A) Alpha 
rarefaction curves showing significant differences in observed species index between ABX-mock (red, n=4) and ABX-
IAV (green, n=3) (p=0.018) but not between CON-mock (blue, n=4) and CON-IAV (black, n=5). (B) Heat map showing 
species-level taxa above 0.1% of abundance. Taxa that reached the significant difference (ANCOM, p<0.05) between 
CON-mock and CON-IAV are designated with *. (C) Heat map showing all taxa selected with ANCOM to be significantly 
different (p<0.05) between ABX-mock (n=4) and ABX-IAV (n=3). 
 
 
Discussion 
Herein, have investigated how ABX treatment of 
juvenile mice impacts on the course of acute IAV infection 
and how IAV infection and ABX treatment modulate GM 
composition. An important feature of our experimental 
design was to focus on juvenile mice, commencing ABX 
treatment immediately after weaning at a time known to 
be important for establishment of the GM [22]. Moreover, 
given that the majority of IAV infections in healthy 
humans do not result in viral pneumonia and severe 
disease, we utilized the HKx31 strain which is of 
moderate virulence in mice [27,29]. To more accurately 
recapitulate the severity of typical human infections in the 
mouse model. 
 
Consistent with studies in adult mice using the 
virulent PR8 strain [9,24]. ABX treatment of juvenile mice 
was associated with enhanced severity of HKx31-induced 
disease and this was characterized by prolonged weight 
loss and enhanced virus growth in the airways. HKx31 
infection induced only minor changes in the GM of control 
mice as mock- and IAV-infected CON mice displayed 
similar GM diversity. However, HKx31 infection of ABX-
treated juvenile mice was associated with a significant 
increase in the GM diversity compared to mock-infected 
ABX-treated mice (ABX-IAV vs. ABX-mock: p = 0.018; 
CON-IAV vs. CON-mock: p = 1.0). Specifically, the relative 
abundance of eight taxa was significantly increased in 
ABX-IAV mice compared to ABX-mock mice. ABX 
treatment alone eradicated most bacteria except 
Parabacteroides distasonis, which is known to be resistant 
to β-lactam antibiotics through production of β-
lactamases, however the abundance of these bacteria was 
further increased during IAV infection of ABX-treated 
mice. We speculate that this could relate to the focus of 
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the immune system, which must adjust from GM 
maintenance towards limiting IAV infection thereby 
facilitating uncontrolled growth of Parabacteroides 
distasonis. Thus, our studies suggest that in the context of 
ABX treatment, a moderate IAV infection represents an 
additional factor that may modulate GM diversity in a 
juvenile population. 
 
Two studies reported that IAV infection of adult SPF 
mice induced changes in the GM composition [9,24]. This 
was associated with increased susceptibility to secondary 
bacterial infections [24]. In these studies, infection of 
adult mice (6-10 weeks of age) with sub-lethal doses of 
PR8 resulted in weight loss, disease and 
immunopathological lung injury [9,24]. PR8 infection was 
also associated with recruitment of T helper 17 (Th17) 
cells and local interferon-γ production to modulate the 
intestinal microbiota (including an increase in 
Enterobacteriaceae), thereby contributing to intestinal 
injury [9]. Furthermore, eradicating most of the GM with a 
broad spectrum ABX or specifically targeting Escherichia 
coli with streptomycin prior to PR8 infection reduced 
pathological injury of the small intestine [9]. In the 
present study, infection of juvenile mice with HKx31 did 
not affect the relative abundance of Enterobacteriaceae in 
CON-IAV mice compared to CON-mock mice, despite clear 
evidence of IAV-induced disease (as evidenced by virus 
replication and weight loss over time). However, ABX 
treatment of mock-infected animals increased the relative 
abundance of Enterobacteriaceae in the gut, which was 
further increased in ABX-IAV mice. Thus, HKx31 infection 
of juvenile mice does not exert the same indirect immune 
modulatory effects as PR8 infection of adult mice with 
regard to Enterobacteriaceae. Nonetheless, the 
combination of ABX-treatment and HKx31infection did 
increase the relative abundance of Enterobacteriaceae. In 
future studies, it will be of interest to determine if the 
abundance of Enterobacteriaceae observed in ABX-IAV 
mice is also associated with enhanced intestinal injury in 
these animals. 
 
In our study, ABX treatment alone reduced overall GM 
diversity while HKx31 infection of ABX-treated mice 
resulted in increased diversity, specifically in regard to 
the relative abundance of eight different bacteria. Five of 
these belonged to the phylum of Bacteroidetes 
(Bacteroides, Bacteroides uniformis, Bacteroides 
acidifaciens, Bacteroidales and Candidate phyla S24-7), as 
well as two Proteobacteria (Sutterella and 
Enterobacteriaceae) and one Verrucomicrobia 
(Akkermansia muciniphila). Akkermansia muciniphila uses 
gastrointestinal mucin as its carbon and nitrogen source 
[41]. The increased presence in ABX-IAV mice suggests 
that viral infection may promote its growth, possibly via 
enhancing mucin production in the gut. This appears 
plausible since (i) it is established that IAV infection in the 
airways can induce immunomodulatory effects in the 
intestines and (ii) that a range of bioactive molecules, 
including cytokines and growth factors, can modulate 
mucin secretion in the gut [42]. In future studies, it would 
be of interest to investigate the relationship between 
growth of Akkermansia muciniphila and the ability of IAV 
infection to induce mucin secretion in the gut of ABX-
treated and control animals. 
 
Despite the increase in GM diversity between ABX-IAV 
and ABX-mock animals, ABX treatment prior to and 
during IAV infection was associated with exacerbated 
weight loss as well as enhanced virus replication in the 
airways. In future studies it will be of interest to 
investigate mechanisms underlying the ability of a 
moderate IAV infection to promote enhanced growth of 
specific gut bacteria in ABX-compromised mice. Further, 
it will be important to clarify the role of the enhanced GM 
diversity as it did not ameliorate disease severity in IAV-
infected animals. Whether IAV-induced changes in ABX-
compromised GM play any role in modulating disease 
severity should be the focus of future studies. 
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